Taro Shuin
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 53
- Cancer Genomics and Diagnostics 25
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 53
- Photodynamic Therapy Research Studies 24
- Prostate Cancer Treatment and Research 24
- Molecular Biology top 1%
- Renal and related cancers 42
- Epigenetics and DNA Methylation 25
- Oncology top 2%
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 58
Taro Shuin
282 papers receiving 8.4k citations
Peers
Comparison fields: 5 of 145
- Cancer Research 2.5k
- Pulmonary and Respiratory Medicine 2.7k
- Molecular Biology 4.4k
- Oncology 1.6k
- Surgery 1.7k
Countries citing papers authored by Taro Shuin
This map shows the geographic impact of Taro Shuin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taro Shuin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taro Shuin more than expected).
Fields of papers citing papers by Taro Shuin
This network shows the impact of papers produced by Taro Shuin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taro Shuin. The network helps show where Taro Shuin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Taro Shuin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 8 | |
| 2 | 2016 | 15 | |
| 3 | 2016 | 21 | |
| 4 | 2013 | 34 | |
| 5 | 2011 | 6 | |
| 6 | 2010 | 79 | |
| 7 | 2010 | 15 | |
| 8 | 2009 | 156 | |
| 9 | 2006 | 52 | |
| 10 | 2005 | 82 | |
| 11 | 2004 | 15 | |
| 12 | [Development of human renal cell carcinoma (RCC)--the responsible genes for the development of hereditary and sporadic human RCCs]. | 2002 | 1 |
| 13 | High expression of the Cap43 gene in infiltrating macrophages of human renal cell carcinomas. | 2001 | 52 |
| 14 | Inhibition of angiogenesis by interferon-alpha in human transitional cell carcinoma growing orthotopically in nude mice and study of combination therapy with cytoreductive chemotherapy | 2001 | 1 |
| 15 | Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. | 2001 | 50 |
| 16 | MOLECULAR GENETICS OF THE KIDNEY CANCERS ; IMPLICATION OF THE VHL TUMOR SUPPRESSOR GENE | 1999 | 1 |
| 17 | [A case of congenital mesoblastic nephroma in adulthood]. | 1998 | 2 |
| 18 | [Results of mutation analyses of von Hippel-Lindau disease gene in Japanese patients: comparison with results in United States and United Kingdom]. | 1995 | 7 |
| 19 | 1995 | 62 | |
| 20 | 1994 | 38 |
About Taro Shuin
Taro Shuin is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Surgery, having authored 290 papers that have together received 8.5k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (58 papers), Renal cell carcinoma treatment (53 papers), Cancer, Hypoxia, and Metabolism (53 papers), Renal and related cancers (42 papers), Cancer Genomics and Diagnostics (25 papers), Epigenetics and DNA Methylation (25 papers), Photodynamic Therapy Research Studies (24 papers) and Prostate Cancer Treatment and Research (24 papers). The work is most often cited by research in Cancer Research (2.5k citations), Pulmonary and Respiratory Medicine (2.7k citations), Molecular Biology (4.4k citations), Oncology (1.6k citations) and Surgery (1.7k citations). Taro Shuin has collaborated with scholars based in Japan, United States and Czechia. Frequent co-authors include Keiji Inoue, Mutsuo Furihata, Masahiko Hosaka, Y. Kubota, Tomoaki Fujioka, Shingo Ashida, Toyomasa Katagiri, Soichiro Torigoe, Tsuneharu Miki and Yoshinobu Kubota. Their work appears in journals such as The Journal of Urology, International Journal of Urology, Cancer Research, Cancer Science and Medical Molecular Morphology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.